YTHDC2 was found to be markedly down-regulated in obese mice and its overexpression improved the liver steatosis and insulin resistance through binding to the mRNA of lipogenic genes (Zhou et al. 2020). This evidence concerns the gene YTHDC2 and Insulin resistance.